The difference was, however, mild and did not reach statistical significance at any time point ( Supplementary Figure S3 ).
← all excerpts
Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes.
1
—
—
The difference was, however, mild and did not reach statistical significance at any time point ( Supplementary Figure S3 ).